血管迷走神経性失神治療の世界市場レポート 2025年

血管迷走神経性失神治療市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.2％で、21億3,000万米ドルに成長します。予測期間中の成長は、個別化医療の進歩、神経心原性メカニズムへの注目の高まり、心理的要因への認識の高まり、集学的ケアの統合の進展、社会的意識の高まりといった要因に起因すると考えられます。この期間の主な動向には、デジタルヘルスツールの統合、集学的ケアの継続、薬理学的イノベーション、ウェアラブル技術と遠隔モニタリング、人工知能（AI）と機械学習の利用などが含まれます。

心血管問題の有病率の増加は、血管迷走神経性失神治療市場の拡大を促進すると予想されます。心血管問題には、心臓病、高血圧、脳卒中、不整脈など、心臓や血管に影響を及ぼすさまざまな状態が含まれます。これらの問題は、主に加工食品、飽和脂肪、高ナトリウムの過剰摂取などの不健康な食生活によって引き起こされ、高血圧、肥満、高コレステロールなどの状態を引き起こし、これらすべてが心臓病のリスクを著しく高める。血管迷走神経性失神の治療は、血圧を安定させ、自律神経の調節を改善し、失神や重要臓器への血流低下を引き起こす心拍数の急激な低下を防ぐことで、心臓血管系の問題を管理するのに役立ちます。例えば、2025年1月、米国心臓協会によると、2022年の米国における死亡者数は94万1,652人で、前年に比べ1万人以上増加しました。その結果、心血管問題の増加が血管迷走神経性失神治療市場の成長に寄与しています。

遠隔医療サービスの拡大は、血管迷走神経性失神治療市場の成長をさらに促進すると予想されます。遠隔医療サービスは、ビデオ通話や電話、オンラインプラットフォームなどのデジタル通信技術を活用して遠隔でヘルスケアを提供するもので、患者は医療機関を訪れることなく医療専門家に相談することができます。このような拡大は、便利なヘルスケアアクセスに対する需要の高まりに後押しされたものであり、より多くの患者が遠隔での診察を求めることで、特に地方や十分なサービスを受けていない地域において、対面での診察の必要性を減らし、より高い柔軟性を提供しています。血管迷走神経性失神治療は、遠隔モニタリング、バーチャル診察、タイムリーな介入を可能にし、アクセシビリティと個別ケアを改善することで、遠隔医療サービスから利益を得ています。例えば、Rock Health社が2023年2月に行った調査では、回答者の80％がある時点で遠隔医療サービスを利用したことがあり、2021年から8ポイント増加したことが明らかになりました。したがって、遠隔医療サービスの拡大が血管迷走神経性失神治療市場の成長を加速させています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界血管迷走神経性失神治療PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の血管迷走神経性失神治療市場：成長率分析
• 世界の血管迷走神経性失神治療市場の実績：規模と成長, 2019-2024
• 世界の血管迷走神経性失神治療市場の予測：規模と成長, 2024-2029, 2034F
• 世界血管迷走神経性失神治療総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の血管迷走神経性失神治療市場治療方法別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬
• ライフスタイルの変更
• 外科的介入
• 心理療法
• 世界の血管迷走神経性失神治療市場診断タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心電図
• 傾斜テーブルテスト
• 電気生理学的研究
• 世界の血管迷走神経性失神治療市場患者の年齢層別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 小児科
• 成人用
• 高齢者
• 世界の血管迷走神経性失神治療市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心臓性
• 神経学的
• 代謝
• 血管運動
• その他の用途
• 世界の血管迷走神経性失神治療市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 専門クリニック
• 家
• ヘルスケア
• 世界の血管迷走神経性失神治療市場、医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 処方薬
• 市販薬（OTC）
• ハーブ薬または代替薬
• 注射または点滴
• 世界の血管迷走神経性失神治療市場ライフスタイル変更のサブセグメンテーション（タイプ別）、実績と予測, 2019-2024, 2024-2029F, 2034F
• 食生活の変化
• 身体活動
• 睡眠衛生
• ストレス管理
• 物質回避
• 世界の血管迷走神経性失神治療市場、外科的介入の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 低侵襲手術
• 主要な外科手術
• 美容整形
• 肥満手術
• 整形外科手術
• 世界の血管迷走神経性失神治療市場心理療法の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 認知行動療法（CBT）
• 精神力動的療法
• 弁証法的行動療法（DBT）
• 対人関係療法（IPT）
• グループセラピー
• 家族療法
• 支持療法
• プレイセラピー

第7章 地域別・国別分析

• 世界の血管迷走神経性失神治療市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の血管迷走神経性失神治療市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 血管迷走神経性失神治療市場：競合情勢
• 血管迷走神経性失神治療市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Medtronic plc
• Gilead Sciences Inc.
• Amgen Inc.
• Siemens Healthineers AG
• Stryker Corporation
• Regeneron Pharmaceuticals Inc.
• C.H. Boehringer Sohn AG & Co. KG
• Boston Scientific Corporation
• Terumo Corporation
• Ipsen S.A.
• Amneal Pharmaceuticals Inc.
• Mallinckrodt plc
• Biotronik SE & Co. KG
• AtriCure Inc.
• Impax Laboratories Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 血管迷走神経性失神治療市場2029：新たな機会を提供する国
• 血管迷走神経性失神治療市場2029：新たな機会を提供するセグメント
• 血管迷走神経性失神治療市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Vasovagal syncope (VVS) is a common type of fainting caused by the body's exaggerated response to triggers such as stress, pain, prolonged standing, or heat exposure. This condition occurs due to a sudden drop in heart rate and blood pressure, which leads to reduced blood flow to the brain and temporary loss of consciousness.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary treatment options for vasovagal syncope include medication, lifestyle changes, surgical procedures, and psychological therapy. Medication involves using pharmaceutical agents to treat, control, or prevent diseases and symptoms. Diagnosis is conducted through electrocardiograms, tilt table tests, and electrophysiological studies, applicable to various age groups, including pediatric, adult, and geriatric populations. These treatments are employed for a range of conditions, including cardiogenic, neurological, metabolic, and vasomotor disorders, and are utilized across different healthcare settings, such as hospitals, specialty clinics, and home healthcare environments.

The vasovagal syncope treatment market research report is one of a series of new reports from The Business Research Company that provides vasovagal syncope treatment market statistics, including the vasovagal syncope treatment global market size, regional shares, competitors with the vasovagal syncope treatment market share, detailed vasovagal syncope treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the vasovagal syncope treatment. This vasovagal syncope treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The vasovagal syncope treatment market size has grown strongly in recent years. It will grow from$1.58 billion in 2024 to $1.68 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth during the historical period can be attributed to factors such as the growing use of pharmacological interventions, increasing interest in personalized treatment, a rising number of healthcare professionals, a better understanding of autonomic regulation and the vagus nerve, and improved access to healthcare and treatments.

The vasovagal syncope treatment market size is expected to see strong growth in the next few years. It will grow to$2.13 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth during the forecast period can be attributed to factors such as advancements in personalized medicine, a growing focus on neurocardiogenic mechanisms, increased awareness of psychological factors, greater integration of multidisciplinary care, and rising public awareness. Key trends during this period include the integration of digital health tools, continued multidisciplinary care, pharmacological innovations, wearable technology and remote monitoring, as well as the use of artificial intelligence (AI) and machine learning.

The growing prevalence of cardiovascular issues is expected to drive the expansion of the vasovagal syncope treatment market. Cardiovascular issues encompass a variety of conditions affecting the heart and blood vessels, such as heart disease, hypertension, stroke, and arrhythmias. These issues are primarily driven by unhealthy diets, including excessive consumption of processed foods, saturated fats, and high sodium, which lead to conditions such as hypertension, obesity, and high cholesterol, all of which significantly raise the risk of heart disease. Vasovagal syncope treatments help manage cardiovascular issues by stabilizing blood pressure, improving autonomic regulation, and preventing sudden drops in heart rate that can cause fainting and reduced blood flow to vital organs. For example, in January 2025, the American Heart Association reported that in 2022, 941,652 deaths in the U.S. were attributed to cardiovascular disease, showing an increase of over 10,000 compared to the previous year. As a result, the rise in cardiovascular issues is contributing to the growth of the vasovagal syncope treatment market.

The expansion of telehealth services is expected to further drive the growth of the vasovagal syncope treatment market. Telehealth services utilize digital communication technologies such as video calls, phone calls, and online platforms to provide healthcare remotely, allowing patients to consult healthcare professionals without visiting medical facilities. This expansion is fueled by the growing demand for convenient healthcare access, as more patients seek remote consultations, reducing the need for in-person visits and offering greater flexibility, particularly in rural or underserved areas. Vasovagal syncope treatment benefits from telehealth services by enabling remote monitoring, virtual consultations, and timely interventions, improving accessibility and personalized care. For instance, a February 2023 survey by Rock Health revealed that 80% of respondents had used telemedicine services at some point, an increase of 8 percentage points from 2021. Therefore, the expansion of telehealth services is accelerating the growth of the vasovagal syncope treatment market.

The increasing awareness of lifestyle modifications is expected to contribute significantly to the growth of the vasovagal syncope treatment market. Lifestyle modifications, such as improving diet, exercising, managing stress, and getting enough sleep, are key to enhancing overall health and managing various conditions. The growing awareness of these modifications is driven by heightened health concerns, as individuals adopt healthier habits to prevent chronic diseases. Vasovagal syncope treatment includes lifestyle adjustments such as staying hydrated, regulating salt intake, avoiding triggers, and engaging in regular exercise to prevent fainting episodes and improve general health. For example, a July 2023 report from the Office of National Statistics in the UK showed that more than 86.5% of adults in Great Britain made lifestyle changes between May and June 2023 to address environmental concerns. As a result, the growing focus on lifestyle modifications is propelling the growth of the vasovagal syncope treatment market.

Major players in the vasovagal syncope treatment market are Johnson & Johnson, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Medtronic plc, Gilead Sciences Inc., Amgen Inc., Siemens Healthineers AG, Stryker Corporation, Regeneron Pharmaceuticals Inc., C.H. Boehringer Sohn AG & Co. KG, Boston Scientific Corporation, Terumo Corporation, Ipsen S.A., Amneal Pharmaceuticals Inc., Mallinckrodt plc, Biotronik SE & Co. KG, AtriCure Inc., and Impax Laboratories Inc.

North America was the largest region in the vasovagal syncope treatment market in 2024. The regions covered in vasovagal syncope treatment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the vasovagal syncope treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The vasovagal syncope treatment market consists of revenues earned by entities by providing services such as lifestyle counseling, medication management, device implantation, diagnosis, and evaluation. The market value includes the value of related goods sold by the service provider or included within the service offering. The vasovagal syncope treatment market also includes sales of beta-blockers, selective serotonin reuptake inhibitors (SSRIs), implantable loop recorders, pacemakers, compression garments, and hydration and electrolyte supplements. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Vasovagal Syncope Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vasovagal syncope treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vasovagal syncope treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The vasovagal syncope treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment Method: Medication; Lifestyle Modification; Surgical Intervention; Psychological Therapy
• 2) By Diagnosis Type: Electrocardiogram; Tilt Table Test; Electrophysiological Study
• 3) By Patient Age Group: Pediatric; Adult; Geriatric
• 4) By Application: Cardiogenic; Neurological; Metabolic; Vasomotor; Other Applications
• 5) By End User: Hospitals; Specialty Clinics; Home; Healthcare
• Subsegments:
• 1) By Medication: Prescription Drugs; Over-The-Counter (OTC) Medications; Herbal Or Alternative Medications; Injections Or Infusions
• 2) By Lifestyle Modification: Dietary Changes; Physical Activity; Sleep Hygiene; Stress Management; Substance Avoidance
• 3) By Surgical Intervention: Minimally Invasive Surgeries; Major Surgical Procedures; Cosmetic Surgery; Bariatric Surgery; Orthopedic Surgeries
• 4) By Psychological Therapy: Cognitive Behavioral Therapy (CBT); Psychodynamic Therapy; Dialectical Behavior Therapy (DBT); Interpersonal Therapy (IPT); Group Therapy; Family Therapy; Supportive Therapy; Play Therapy
• Companies Mentioned: Johnson & Johnson; Sanofi S.A.; Bristol-Myers Squibb Company; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Vasovagal Syncope Treatment Market Characteristics

3. Vasovagal Syncope Treatment Market Trends And Strategies

4. Vasovagal Syncope Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Vasovagal Syncope Treatment Growth Analysis And Strategic Analysis Framework

• 5.1. Global Vasovagal Syncope Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Vasovagal Syncope Treatment Market Growth Rate Analysis
• 5.4. Global Vasovagal Syncope Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Vasovagal Syncope Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Vasovagal Syncope Treatment Total Addressable Market (TAM)

6. Vasovagal Syncope Treatment Market Segmentation

• 6.1. Global Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Lifestyle Modification
• Surgical Intervention
• Psychological Therapy
• 6.2. Global Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrocardiogram
• Tilt Table Test
• Electrophysiological Study
• 6.3. Global Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pediatric
• Adult
• Geriatric
• 6.4. Global Vasovagal Syncope Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiogenic
• Neurological
• Metabolic
• Vasomotor
• Other Applications
• 6.5. Global Vasovagal Syncope Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Specialty Clinics
• Home
• Healthcare
• 6.6. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Medication, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prescription Drugs
• Over-The-Counter (Otc) Medications
• Herbal Or Alternative Medications
• Injections Or Infusions
• 6.7. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Lifestyle Modification, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dietary Changes
• Physical Activity
• Sleep Hygiene
• Stress Management
• Substance Avoidance
• 6.8. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Surgical Intervention, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Minimally Invasive Surgeries
• Major Surgical Procedures
• Cosmetic Surgery
• Bariatric Surgery
• Orthopedic Surgeries
• 6.9. Global Vasovagal Syncope Treatment Market, Sub-Segmentation Of Psychological Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cognitive Behavioral Therapy (CBT)
• Psychodynamic Therapy
• Dialectical Behavior Therapy (DBT)
• Interpersonal Therapy (IPT)
• Group Therapy
• Family Therapy
• Supportive Therapy
• Play Therapy

7. Vasovagal Syncope Treatment Market Regional And Country Analysis

• 7.1. Global Vasovagal Syncope Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Vasovagal Syncope Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Vasovagal Syncope Treatment Market

• 8.1. Asia-Pacific Vasovagal Syncope Treatment Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Vasovagal Syncope Treatment Market

• 9.1. China Vasovagal Syncope Treatment Market Overview
• 9.2. China Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Vasovagal Syncope Treatment Market

• 10.1. India Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Vasovagal Syncope Treatment Market

• 11.1. Japan Vasovagal Syncope Treatment Market Overview
• 11.2. Japan Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Vasovagal Syncope Treatment Market

• 12.1. Australia Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Vasovagal Syncope Treatment Market

• 13.1. Indonesia Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Vasovagal Syncope Treatment Market

• 14.1. South Korea Vasovagal Syncope Treatment Market Overview
• 14.2. South Korea Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Vasovagal Syncope Treatment Market

• 15.1. Western Europe Vasovagal Syncope Treatment Market Overview
• 15.2. Western Europe Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Vasovagal Syncope Treatment Market

• 16.1. UK Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Vasovagal Syncope Treatment Market

• 17.1. Germany Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Vasovagal Syncope Treatment Market

• 18.1. France Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Vasovagal Syncope Treatment Market

• 19.1. Italy Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Vasovagal Syncope Treatment Market

• 20.1. Spain Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Vasovagal Syncope Treatment Market

• 21.1. Eastern Europe Vasovagal Syncope Treatment Market Overview
• 21.2. Eastern Europe Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Vasovagal Syncope Treatment Market

• 22.1. Russia Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Vasovagal Syncope Treatment Market

• 23.1. North America Vasovagal Syncope Treatment Market Overview
• 23.2. North America Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Vasovagal Syncope Treatment Market

• 24.1. USA Vasovagal Syncope Treatment Market Overview
• 24.2. USA Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Vasovagal Syncope Treatment Market

• 25.1. Canada Vasovagal Syncope Treatment Market Overview
• 25.2. Canada Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Vasovagal Syncope Treatment Market

• 26.1. South America Vasovagal Syncope Treatment Market Overview
• 26.2. South America Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Vasovagal Syncope Treatment Market

• 27.1. Brazil Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Vasovagal Syncope Treatment Market

• 28.1. Middle East Vasovagal Syncope Treatment Market Overview
• 28.2. Middle East Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Vasovagal Syncope Treatment Market

• 29.1. Africa Vasovagal Syncope Treatment Market Overview
• 29.2. Africa Vasovagal Syncope Treatment Market, Segmentation By Treatment Method, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Vasovagal Syncope Treatment Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Vasovagal Syncope Treatment Market, Segmentation By Patient Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Vasovagal Syncope Treatment Market Competitive Landscape And Company Profiles

• 30.1. Vasovagal Syncope Treatment Market Competitive Landscape
• 30.2. Vasovagal Syncope Treatment Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Vasovagal Syncope Treatment Market Other Major And Innovative Companies

• 31.1. Medtronic plc
• 31.2. Gilead Sciences Inc.
• 31.3. Amgen Inc.
• 31.4. Siemens Healthineers AG
• 31.5. Stryker Corporation
• 31.6. Regeneron Pharmaceuticals Inc.
• 31.7. C.H. Boehringer Sohn AG & Co. KG
• 31.8. Boston Scientific Corporation
• 31.9. Terumo Corporation
• 31.10. Ipsen S.A.
• 31.11. Amneal Pharmaceuticals Inc.
• 31.12. Mallinckrodt plc
• 31.13. Biotronik SE & Co. KG
• 31.14. AtriCure Inc.
• 31.15. Impax Laboratories Inc.

32. Global Vasovagal Syncope Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Vasovagal Syncope Treatment Market

34. Recent Developments In The Vasovagal Syncope Treatment Market

35. Vasovagal Syncope Treatment Market High Potential Countries, Segments and Strategies

• 35.1 Vasovagal Syncope Treatment Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Vasovagal Syncope Treatment Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Vasovagal Syncope Treatment Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r35015_Vasovagal_Syncope_Treatment_GMR_2025